Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

ClinicalTrials.gov ID: NCT00595920

Public ClinicalTrials.gov record NCT00595920. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 4:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension Study to Evaluate the Safety, Tolerability and Efficacy of Subcutaneous Tovaxin in Subjects Previously Treated in the TERMS Study 2005-00

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to further evaluate the safety and efficacy of Tovaxin in the treatment of relapsing forms of multiple sclerosis.

Study identification

NCT ID
NCT00595920
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Opexa Therapeutics, Inc.
Industry
Enrollment
116 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2007 (Type not available)
Primary completion
Dec 2008 (Actual)
Completion
Dec 2008 (Actual)
Last update posted
Mar 15, 2016

2007 – 2008

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
North Central Neurology Associates, PC Cullman Alabama 35058 —
Xenoscience - 21st Century Neurology Phoenix Arizona 85013 —
HOPE Research Institute Phoenix Arizona 85050 —
Alta Bates Summit Medical Center - East Bay Physicians Medical Group Berkeley California 94705 —
Patricia A Fodor, PC Colorado Springs Colorado 80919 —
Bradenton Neurology Bradenton Florida 34205 —
Neurological Associates Pompano Beach Florida 33060 —
Medical College of Georgia - Department of Neurology Augusta Georgia 30912 —
Consultants in Neurology, Ltd. Northbrook Illinois 60062 —
Allied Physicians Inc Fort Wayne Indiana 46805 —
MidAmerica Neuroscience Institute Lenexa Kansas 66214 —
Associates in Neurology Lexington Kentucky 40503 —
St Mary's of Michigan - Field Neuroscience Institute Saginaw Michigan 48604 —
Ayres & Associates Clinical Trials Lebanon New Hampshire 03766 —
Upstate Clinical Research, LLC Albany New York 12205 —
Winthrop University Hospital - Clinical Trials Unit Mineola New York 11501 —
Neurology Consultants of the Carolinas, PA Charlotte North Carolina 28204 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
Neurology & Neuroscience Associates, Inc. Akron Ohio 44302 —
Neurological Research Institute Columbus Ohio 43221 —
Neurology Specialists, Inc Dayton Ohio 45408 —
Providence St. Vincent Medical Center - Northwest MS Center Portland Oregon 97225 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
The Maxine Mesinger MS Clinic/Baylor College of Medicine Houston Texas 77030 —
Central Texas Neurology Round Rock Texas 78681 —
Integra Clinical Research, LLC San Antonio Texas 78229 —
MS Center at Evergreen Kirkland Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00595920, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 15, 2016 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00595920 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →